hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 16:45:15 - browse：224

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Headspace, Meta partner to launch VR meditation app for Quest

WSS

Malaria cases in Florida and Texas: Here’s what you need to know

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Alkermes shareholders re

Novo Nordisk obesity pill bests Wegovy in early trial

Wikipedia

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Sen. Paul opposes bill to ban Chinese biotechs

Duchenne breakthrough therapy leaves behind pioneering families

Precocious puberty in girls comes with mental health risks

As demand for Covid shots wanes, Moderna seeks its next success

Sen. Paul opposes bill to ban Chinese biotechs

Tori Bowie and the unacceptable rates of Black maternal death

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

George Santos makes 1st court appearance after pleading not guilty to 13 counts

With psoriasis trial ahead, Alumis raises $259 million

explore

In age of alternative facts, a scholarly course on calling out crap

Amylyx ALS drug failure raises questions and concerns

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

State Dept. review finds Biden bears some blame for Afghanistan failures

Wikipedia

leisure time

focus

knowledge